CasNo.90045-38-8,Panax Ginseng Extract Powder CAS NO.90045-38-8,(90045-38-8) Suppliers

1 Kilogram	Negotiable

Min.Order :1 Kilogram
Purity: 98%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

Panax Ginseng Extract Powder low price Panax Ginseng Extract Powder 90045-38-8

Quick Details

Appearance:Off-white powder
Application:Pharma;Industry;Food
PackAge:1g~5kgFood grade multiplayer polyethylene bags;25kg in one type cardboard drum ,or according to your requests.
ProductionCapacity:300|Kilogram|Day
Storage:in sealed air resistant place
Transportation:by courier/air/sea

Superiority:

1)Quick Response Within 12 hours;

2)Quality Guarantee: All products are strictly tested by our QC, confirmed by QA and approved by third party lab in China, USA, Canada, Germany, UK, Italy, France etc.

3) OEM/ODM Available;

4) Reasonable & Competitive Price;

5) Fast Delivery: Samples from stock; bulk products within 7 days;

6) Professional Documents for Your Clearance;

7) Economic Freight Save Your Cost;

8) All your money be refund immediately if quality issue happens.

Details:

Type:Ginseng Root Extract, Health Care

Form:Powder

Part:Root

Extraction Type:Solvent Extraction

Packaging:Bottle, Drum, Glass Container, Plastic Container

Grade:Top Quality

Product Name:Ginsenoside Rg3

Appearance:Off-white powder

MOQ:5G

MF:C15H24N2O

Test Method:UV

Specification:98%

CAS:90045-38-8

Active Ingredient:Ginsenoside Rg3

Information
Product	Ginsenoside Rg3
Specification	98%
Botanical Source	Ginseng Extract
Latin Name	Panax ginseng L
Test Method	UV
Appearance	Off-White Powder
CAS	90045-38-8
MF	C15H24N2O
MW	248.37
Storage	Store in cool & dry place.Keep away from strong light and heat.
Shelf life	24 months when properly stored.

What is Ginsenoside Rg3

Ginsenoside Rg3 is a natural product isolated from Panax ginseng. Similar to other ginsenosides it exhibits cardio protective effects. Ginsenoside Rg3 enhances cardiac, hERG (IKr) and KCNQ (Iks), channel currents by interaction with the channel pore entryway. It also inhibits the palmitate-induced apoptosis of MIN6N8 mouse insulinoma beta-cells through modulating p44/42 MAPK activation. Ginsenoside Rg3 increases the level of the transcription factor Nrf2 and induces the mRNA levels of multidrug resistance-associated protein (Mrp) 1 and Mrp3.Rg3 modulate neuroinflammation by attenuating the activation of microglia in response to systemic LPS treatment. It activates AMPK in HepG2 cells and reduces the lipid accumulation thereby decreasing the risk of cardiovascular disease due to dyslipidemia.